Back to Archived Journals » Transplant Research and Risk Management » Volume 3
Transplant Research and Risk Management ceased publishing in April 2025. All articles that have been published in Transplant Research and Risk Management will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Transplant Research and Risk Management
- View all (91)
- Volume 16, 2024 (2)
- Volume 15, 2023 (1)
- Volume 14, 2022 (6)
- Volume 13, 2021 (3)
- Volume 12, 2020 (5)
- Volume 11, 2019 (8)
- Volume 10, 2018 (1)
- Volume 9, 2017 (7)
- Volume 8, 2016 (5)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5 , 2013 (3)
- Volume 4, 2012 (5)
- Volume 3, 2011 (10)
- Volume 2, 2010 (13)
- Volume 1, 2009 (2)
Archive: Volume 3, 2011
Facial transplantation: a review of ethics, progress, and future targets
Edwards JA, Mathes DW
Transplant Research and Risk Management 2011, 3:113-125
Published Date: 5 September 2011
Everolimus in kidney transplantation
Cooper JE, Christians U, Wiseman AC
Transplant Research and Risk Management 2011, 3:97-112
Published Date: 8 July 2011
Evaluation of medication errors via a computerized physician order entry system in an inpatient renal transplant unit
Marfo K, Garcia D, Khalique S, Berger K, Lu A
Transplant Research and Risk Management 2011, 3:91-96
Published Date: 18 May 2011
Long-term outcome of everolimus treatment in transplant patients
Salvadori M, Bertoni E
Transplant Research and Risk Management 2011, 3:77-90
Published Date: 13 May 2011
Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients
Martin ST, Tsapepas D, Gabardi S, Chandraker A
Transplant Research and Risk Management 2011, 3:65-75
Published Date: 12 April 2011
Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials
Jackson RM, Gomez-Marin O
Transplant Research and Risk Management 2011, 3:55-63
Published Date: 11 April 2011
Mycophenolic acid agents: is enteric coating the answer?
Manitpisitkul W, Lee S, Cooper M
Transplant Research and Risk Management 2011, 3:45-53
Published Date: 29 March 2011
Pathophysiology, prevention, and treatment of acute graft-versus-host disease
Abhinav Deol, Voravit Ratanatharathorn, Joseph P Uberti
Transplant Research and Risk Management 2011, 3:31-44
Published Date: 7 March 2011
Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation
Helio Tedesco-Silva Jr, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, et al
Transplant Research and Risk Management 2011, 3:9-29
Published Date: 24 January 2011
Human amniotic membrane, best healing accelerator, and the choice of bone induction for vestibuloplasty technique (an animal study)
Mohammad H Samandari, Shahriar Adibi, Ahad Khoshzaban, et al
Transplant Research and Risk Management 2011, 3:1-8
Published Date: 22 December 2010